Clara Larew, APRN
Primary Care · Bridgeport, WVNPI 1376263483
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $563 and has fallen 84.2% since, to $89 in 2025.
Across 44 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$134
- Exact Sciences$119
- Bayer$98
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$50
- Xeris Pharmaceuticals, Inc.$48
- Amgen$43
- plus $258 from 10 others
What the payments were for
- Food & beverage$750100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 9 | $134 |
| Exact Sciences | 6 | $119 |
| Bayer | 6 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Amgen | 3 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $33 |
| Merck | 1 | $31 |
| Dexcom, Inc. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| AstraZeneca | 2 | $28 |
| Novartis | 1 | $19 |
| AbbVie | 1 | $19 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
How this compares
$750 in reported general payments places this provider in the 60th percentile of 43 primary care providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 16 | $181 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $126 |
| Azithromycin | 14 | $64 |
| Prednisone | 19 | $50 |
Paid to pharmacies, not to this prescriber.
Other primary care in Bridgeport
- Jordan KeslerBridgeport$1K
- Destiny WilliamsBridgeport$153
- Marissa Barberio-SaasBridgeport$24
- Sariah WaldronBridgeport$22
- Amanda WakimWheeling$169K
- Brenda HashemBerkeley Springs$8K
- Brenda DennisGlen Dale$6K
- Molly WhiteCharleston$5K
- Richard SutherlandMartinsburg$4K
- Kayla MeadeHuntington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.